Peking University, November 15, 2023: Recently, the launching ceremony of the Peking University Health Science Center- AstraZeneca Joint Real-World Research Lab was held at the 6th China International Import Expo (CIIE) in Shanghai.


Xiao Yuan, vice president of Peking University Health Science Center (PKUHSC), pointed out in his speech during the launching ceremony that PKU Medicine, together with AstraZeneca, would strive to attract top international and domestic experts, form a first-class real-world research team and undertake major national scientific research tasks to build a first-class real-world research platform in China.

 
Carmen Moreno, head of the China Branch of AstraZeneca Global Evidence Center and a major participant in the Joint Lab, stated that the lab would collaborate with local health systems and clinical researchers in China to promote innovation in clinical practice through high-quality real-world evidence, maximize patient benefits, and help enhance the global influence of China's real-world evidence industry.


At the launching ceremony, Xiao Yuan and Carmen Moreno signed an agreement of the Joint Lab on behalf of PKUHSC and AstraZeneca respectively, while Sun Feng and Carmen Moreno unveiled the Joint Lab. In the future, both sides will jointly explore and conduct real-world research, enrich the evidence of evidence-based medicine, and promote the clinical diagnosis and treatment of chronic diseases and the development of public health.

This article was featured in the special coverage of PKU's Global Engagement Year.


Written by: Wu Zhaoxia 
Edited by: Dennis Meng
Source: School of Public Health